What is GLP-2? Why tirzepatide isn’t a GLP-2 drug

If you’ve been reading about GLP-1 medications, you probably know that GLP-1 stands for glucagon-like peptide-1, a hormone involved in blood sugar regulation and appetite. Medications like Wegovy® and Ozempic® mimic the effects of GLP-1, while tirzepatide—the active ingredient in Zepbound® and Mounjaro®—targets two hormones: GLP-1 and GIP.

That can lead to some confusion about the term “GLP-2.” Tirzepatide is sometimes mistakenly described as a GLP-2 drug because it targets two hormones, but GLP-2 doesn’t mean “two GLPs” or “two gut hormones.” It stands for glucagon-like peptide-2, a separate hormone with a very different role in the body.

Here’s how GLP-2 differs from GLP-1 and GIP, whether it has any potential role in weight management, and what it has—and doesn’t have—to do with today’s weight-loss medications.

What is GLP-2?

So, what is GLP-2? GLP-2 stands for glucagon-like peptide-2. It’s a hormone produced in the intestines and released in response to food. GLP-1 and GLP-2 actually come from the same precursor molecule, called proglucagon, but they go on to have very different effects in the body.

⁠Research shows that GLP-2 helps support the growth and repair of the intestinal lining, increases intestinal blood flow, strengthens the intestinal barrier, and helps the gut absorb nutrients. These effects are especially important for people who have lost a significant amount of functioning intestine or can’t absorb enough fluids and nutrients normally.

That’s very different from GLP-1’s best-known effects. GLP-1 helps regulate blood sugar, influences appetite and fullness, and slows how quickly food moves through the stomach. Those effects help explain why medications that activate GLP-1 receptors can be used to treat type 2 diabetes or obesity.

Why does tirzepatide sometimes get called a “GLP-2”?

The confusion likely comes from the way these medications are discussed. Semaglutide is a GLP-1 receptor agonist, meaning it targets one hormone pathway: GLP-1. Tirzepatide is called a dual agonist because it targets two: GLP-1 and GIP. And an experimental medication called retatrutide goes one step further, targeting three hormone pathways—GLP-1, GIP, and glucagon—which is why it’s known as a triple agonist.

On social media, those terms sometimes get shortened incorrectly: tirzepatide may be called a “GLP-2,” while retatrutide may be called a “GLP-3.” But the numbers don’t work that way. GLP-2 is the name of a specific hormone, not shorthand for a medication that targets two hormones. Likewise, there is no “GLP-3” hormone involved in retatrutide.

GIP’s role in weight regulation is more complicated than GLP-1’s, and researchers are still working out exactly how the two pathways interact to produce tirzepatide’s effects on appetite and weight. 

Read more: GLP-1 vs. GIP: What’s the difference, and does it matter for weight loss?

What’s the difference between GLP-1 and GLP-2?

GLP-1, or glucagon-like peptide-1, is a hormone released by the gut after you eat. It helps your body respond to food by increasing insulin release when blood sugar is elevated, reducing glucagon, slowing how quickly food leaves the stomach, and sending signals that can increase fullness and reduce appetite.

These effects are why GLP-1 has become an important target for both diabetes and weight-loss medications. Semaglutide, the active ingredient in Ozempic® and Wegovy®, works by activating GLP-1 receptors and lasts much longer in the body than naturally occurring GLP-1.

GLP-2 has a very different primary job. Rather than being best known for regulating blood sugar and appetite, it acts mainly on the intestines, where it supports the intestinal lining and helps promote nutrient and fluid absorption.

GLP-1 vs. GLP-2: What to know about the differences

Despite their similar names, GLP-1 and GLP-2 have very different roles in the body. Here’s a quick look at how they compare, including what they do, the medications that mimic them, and whether they have a role in weight management.

	GLP-1	GLP-2
What is it?	A natural gut hormone	A natural gut hormone
Main role	Blood sugar regulation, appetite, fullness, and digestion	Intestinal growth, repair, and nutrient and fluid absorption
Connection to weight loss	Well-established medication target	No established role in weight management
Example medication that mimics its effects	Semaglutide and tirzepatide (also GIP)	Teduglutide
Available for weight management?	Yes, depending on the medication	No

What are GLP-2 medications?

GLP-2 medications exist, but they aren’t used for weight loss. Instead, they’re used to help people who have trouble absorbing enough nutrients and fluids through their intestines.

One example is teduglutide (Gattex®), a medication that mimics the effects of natural GLP-2. It’s approved to treat certain people with short bowel syndrome who need nutrition and fluids through an IV. Short bowel syndrome is a condition in which a person doesn’t have enough functioning small intestine to absorb what their body needs.

Researchers have also studied other GLP-2 medications, including longer-acting options like glepaglutide, for people with short bowel syndrome.

What is “GLP-3”?

Unlike GLP-1 and GLP-2, there isn’t an established human hormone called GLP-3. Instead, “GLP-3” is sometimes used as a nickname for retatrutide, an investigational medication that targets three hormone pathways: GLP-1, GIP, and glucagon.

That makes retatrutide a triple agonist. But the “3” doesn’t mean it targets a GLP-3 hormone or receptor—it simply refers to the three pathways the medication targets.

Retatrutide is still being studied and isn’t currently available by prescription. The important distinction is that “GLP-3” is an informal nickname, while GLP-2 is the name of an actual hormone.

Read more: What is a GLP-3? Retatrutide’s popular nickname explained 

Could GLP-2 eventually be used for weight loss?

Possibly, but the research is still early. GLP-2 isn’t currently approved for weight management, but researchers are studying whether targeting GLP-2 along with other hormone pathways could eventually play a role.

One example is dapiglutide, an experimental medication that targets both GLP-1 and GLP-2 receptors. That makes it a true GLP-1/GLP-2 dual agonist—unlike tirzepatide, which targets GLP-1 and GIP.

In a 2026 phase 2a study of adults with obesity, researchers tested dapiglutide’s effects on body weight and other measures. While some weight loss was seen, the study didn’t establish a clear weight-loss benefit over placebo at the doses and treatment duration studied.

For now, GLP-2’s role in weight management remains experimental. More research will be needed to determine whether combining GLP-2 with pathways like GLP-1 could offer benefits for weight loss.

Frequently asked questions about GLP-2

What is the difference between GLP-1 and GLP-2?

Both are natural gut hormones, but they have different primary roles. GLP-1 helps regulate blood sugar, appetite, fullness, and digestion. GLP-2 acts mainly on the intestines, where it supports growth, repair, and nutrient absorption.

What are GLP-2 medications?

Teduglutide (Gattex®) is a GLP-2 analog used to treat people with short bowel syndrome who require parenteral support. Other GLP-2 analogs, including glepaglutide, have also been studied.

Does GLP-2 work for weight loss?

GLP-2 isn’t currently an approved weight-loss treatment. Researchers are testing experimental drugs that combine GLP-2 with other pathways, including GLP-1, but it’s too early to know what role GLP-2 could have in future obesity treatment.

Does GIP cause weight loss?

We can’t say that GIP alone causes weight loss. Tirzepatide activates GIP and GLP-1 receptors together and can produce significant weight loss, but researchers are still studying exactly how much each pathway contributes.

Read more: GLP-1 vs. GIP: What’s the difference for weight loss?

Is tirzepatide a GLP-2?

No. Tirzepatide activates GLP-1 and GIP receptors, making it a dual GIP/GLP-1 receptor agonist. GLP-2 is a separate natural hormone that primarily acts on the intestines.

GLP-1 vs. GLP-2 vs. “GLP-3”: What’s the difference?

GLP-1, GLP-2, and “GLP-3” sound like they should be three versions of the same thing, but they aren’t. GLP-1 and GLP-2 are naturally occurring hormones, while “GLP-3” is an informal nickname sometimes used for retatrutide.

Is GLP-3 a real hormone?

No. GLP-1 and GLP-2 are natural hormones, but there isn’t an established human hormone called GLP-3. “GLP-3” is an unofficial nickname sometimes used for retatrutide because it targets three receptors: GLP-1, GIP, and glucagon.

The bottom line: GLP-2 isn’t yet used for weight loss

GLP-1, GLP-2, and “GLP-3” can sound like different generations of the same type of weight-loss medication, but they mean very different things. GLP-1 and GLP-2 are real hormones with different roles in the body, while “GLP-3” is an informal nickname sometimes used for retatrutide.

GLP-2 primarily supports intestinal health and nutrient absorption, which is why medications that mimic it are used to treat short bowel syndrome. Tirzepatide, on the other hand, targets GLP-1 and GIP, two hormone pathways involved in blood sugar regulation, appetite, and the body’s response to food.

Researchers are beginning to study medications that combine GLP-2 activity with other pathways for weight management, but that research is still early. For now, approved weight-loss medications target other pathways, including GLP-1 alone or GLP-1 and GIP together.

If you’re considering tirzepatide or another prescription medication for weight management, see if you qualify for Noom Med. We’ll connect you with a clinician who can review your health history, discuss your options, and prescribe medication if appropriate.